BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 157575)

  • 21. Antibodies to nonpolymorphic determinants of the Thy-1 molecule inhibit T cell proliferation.
    Hollander N
    J Immunol; 1985 May; 134(5):2916-21. PubMed ID: 2858507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mouse-primed lymphocyte typing test. III. Dissociation of T lymphocyte-stimulating determinants and antibody-defined specificities of the I region-associated Ia antigens.
    Peck AB; Klein J; Wigzell H
    J Immunol; 1980 Sep; 125(3):1978-86. PubMed ID: 6157729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. IV. Partial tissue distribution and mapping of immunodominant antigens.
    Wettstein PJ; Colombo MP
    J Immunol; 1987 Oct; 139(7):2166-71. PubMed ID: 2958540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decline in mixed lymphocyte reactivity of spleen cells from aged mice of a long-lived strain.
    Konen TG; Smith GS; Walford RL
    J Immunol; 1973 May; 110(5):1216-21. PubMed ID: 4348973
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic analysis of the presentation of minor lymphocyte-stimulating determinants. II. Differing non-MHC control of super-stimulatory and more poorly stimulatory Mls phenotypes.
    Ryan JJ; LeJeune HB; Mond JJ; Finkelman FD
    J Immunol; 1990 Apr; 144(7):2506-17. PubMed ID: 2138649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific neonatally induced tolerance to Mls locus determinants.
    Macphail S; Ishizaka ST; Bykowsky MJ; Lattime EC; Stutman O
    J Immunol; 1985 Nov; 135(5):2967-74. PubMed ID: 2413106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface IgG-mediated mixed lymphocyte culture and cell-mediated lympholysis responses by immunocompetent thymus cells.
    Dyminski JW
    Thymus; 1981 Nov; 3(4-5):257-75. PubMed ID: 6458934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Stimulating effect of a low-molecular humoral factor of the thymus on lymphoid cell activity in the mixed lymphocyte test].
    Malyzhev VA
    Fiziol Zh; 1977; 23(6):775-9. PubMed ID: 145379
    [No Abstract]   [Full Text] [Related]  

  • 29. Frequency and cross-reactivity od cytolytic T lymphocyte precursors reacting against male alloantigens.
    Kanagawa O; Louis J; Cerottini JC
    J Immunol; 1982 May; 128(5):2362-6. PubMed ID: 6174631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
    Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
    J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro reactivity of lymphoid cells from tolerant mice.
    Beverley PC; Brent L; Brooks C; Medawar PB; Simpson E
    Transplant Proc; 1973 Mar; 5(1):679-84. PubMed ID: 4266673
    [No Abstract]   [Full Text] [Related]  

  • 32. [Specificity of cell-mediated cytotoxicity. II. Cytotoxic lymphocytes after in vitro allogeneic sensitization in the H-2 system].
    Schulze HA; Brock J
    Allerg Immunol (Leipz); 1983; 29(2):100-7. PubMed ID: 6224410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption of normal lymphocytes on allogeneic spleen monolayers: depletion of alloreactivity is due to inhibition of CTL induction by released monolayer cells.
    Kelso A
    J Immunol; 1981 Oct; 127(4):1563-9. PubMed ID: 6456308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cell activation. VI. Inhibitory and stimulatory effects of anti-major histocompatibility complex class I antibodies in allogeneic mixed lymphocyte culture.
    Röpke M; Röpke C; Claësson MH
    Immunology; 1993 Jun; 79(2):263-9. PubMed ID: 8344704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syngeneic mixed lymphocyte reaction between thymocytes and peripheral lymphoid cells in mice: strain specificity and nature of the target cell.
    Von Boehmer H; Adams PB
    J Immunol; 1973 Feb; 110(2):376-83. PubMed ID: 4265142
    [No Abstract]   [Full Text] [Related]  

  • 36. Alloimmunization: induction of antileukemic reactivity without modification of anti-host reactivity in H-2-compatible mice.
    Truitt RL; Bortin MM; Rimm AA
    Transplant Proc; 1980 Mar; 12(1):143-6. PubMed ID: 6966095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that strong Mls determinants are nonpolymorphic.
    Molnar-Kimber KL; Sprent J
    Transplantation; 1981 May; 31(5):376-8. PubMed ID: 6165115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell recognition of Mlsc. I. Influence of MHC gene products in Mlsc-specific T cell recognition.
    Abe R; Hodes RJ
    J Immunol; 1988 Jun; 140(12):4132-8. PubMed ID: 2453568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of H-2 in T cell recognition of Mls.
    Gress RE; Wesley MN; Hodes RJ
    J Immunol; 1981 Nov; 127(5):1763-6. PubMed ID: 6170671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.